Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000910680-04-000296
Filing Date
2004-03-08
Accepted
2004-03-08 13:11:30
Documents
13
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k123103.txt 10-K 373961
3 EXHIBIT 4.10 exhibit4-10for10k.txt EX-4 618
4 EXHIBIT 4.11 exhibit4-11.txt EX-4 5034
5 EXHIBIT 4.12 exhibit4-12.txt EX-4 608
6 EXHIBIT 4.13 exhibit4-13for10k.txt EX-4 4894
7 EXHIBIT 10.2 exhibit10-2for10k.txt EX-10 35027
8 EXHIBIT 10.12 exhibit10-12for10k.txt EX-10 1976
9 LIST OF SUBSIDIARIES ex21_1-123103.txt EX-21 1197
10 CONSENT OF DELOITTE & TOUCHE LLP ex23_1-123103.txt EX-23 737
11 CERTIFICATION OF JAMES R. MURPHY [EX31_1] ex31_1123103.txt EX-31 3122
12 CERTIFICATION OF MICHAEL D. PRICE [EX31_2] ex31_2123103.txt EX-31 3129
13 CERTIFICATION OF JAMES R. MURPHY [EX-32.1] ex32_1123103.txt EX-32 1242
14 CERTIFICATION OF MICHAEL D. PRICE [EX-32.2] ex32_2123103.txt EX-32 1284
  Complete submission text file 0000910680-04-000296.txt   435980
Mailing Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833
Business Address BENTLEY PARK 2 HOLLAND WAY EXETER NH 03833 6036586100
BENTLEY PHARMACEUTICALS INC (Filer) CIK: 0000821616 (see all company filings)

EIN.: 591513162 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10581 | Film No.: 04654208
SIC: 2834 Pharmaceutical Preparations